Lv3
210 积分 2024-12-27 加入
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
1天前
待确认
Lessons learned in linking PROTACs from discovery to the clinic
1个月前
已完结
Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
1个月前
已完结
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
1个月前
已完结
Ring-Enlargement of in Situ Generated Cyclopropanones by the Reaction with Sulfonium Ylides: One-Pot Synthesis of Cyclobutanones
1个月前
已完结
Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges
2个月前
已完结
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs
2个月前
已完结
The coming of age of cyclic peptide drugs: an update on discovery technologies
2个月前
已完结
Discovery of Novel TYRO3/MERTK Dual Inhibitors
3个月前
已完结
A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance
3个月前
已完结
皖公网安备34019202002308
